No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
van den Borne BE, Landewé RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, Zwinderman AH, Goei The HS, Breedveld FC, Bernelot Moens HJ, Kluin PM, Dijkmans BA.
van den Borne BE, et al. Among authors: landewe rb.
Arthritis Rheum. 1998 Nov;41(11):1930-7. doi: 10.1002/1529-0131(199811)41:11<1930::AID-ART6>3.0.CO;2-N.
Arthritis Rheum. 1998.
PMID: 9811046